Rx · PZN 14239986, 14240067, 14239992

ml Solostar solution for injection

German trade nameSULIQUA 100 E-ml + 33 -m63g-ml Solostar Injektionslösung

Active ingredientInsulin glargine and lixisenatideSubstance (DE)Insulin glargin und LixisenatidPharmaceutical formSolution for injection/infusion

Consistently available

9.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Cold chain 2–8 °C

Average purchase price (B2B)

~ €97

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

SULIQUA 100 U/ml + 33 µg/ml Solostar solution for injection is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

SULIQUA 100 U/ml + 33 µg/ml Solostar solution for injection contains the active ingredient Insulin glargine and lixisenatide (German Insulin glargin und Lixisenatid) and comes as Solution for injection/infusion. 3 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 9.6 out of 10. The best-available pack was consistently available.

Pack sizes · 3 PZN

PZN	Index 7 d	Index 30 d	Highest known purchase price
14239986	9.3	9.6	~ €65
14239992	8.8	9.3	~ €129
14240067	0.0	0.0	N/A

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across 2 of 3 PZNs.